Mini Review

Published on 24 Aug 2023

Targeting collagen in tumor extracellular matrix as a novel targeted strategy in cancer immunotherapy

in Cancer Immunity and Immunotherapy

Jiayang Liu
Danjie Pan
Xuan Huang
Songna Wang
Huaning Chen
Yi Zhun Zhu
Li Ye

Frontiers in Oncology

doi 10.3389/fonc.2023.1225483

2,888 views
5 citations

Review

Published on 24 Aug 2023

Research progress of nanovaccine in anti-tumor immunotherapy

in Cancer Immunity and Immunotherapy

Min Yao
Xiyu Liu
Zhangbo Qian
Dianfa Fan
Xinjun Sun
Liping Zhong
Pan Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1211262

3,926 views
10 citations

Review

Published on 23 Aug 2023

Harnessing the immunomodulatory effects of exercise to enhance the efficacy of monoclonal antibody therapies against B-cell haematological cancers: a narrative review

in Cancer Immunity and Immunotherapy

Harrison D. Collier-Bain
Frankie F. Brown
Adam J. Causer
Annabelle Emery
Rebecca Oliver
Sally Moore
James Murray
James E. Turner
John P. Campbell

Frontiers in Oncology

doi 10.3389/fonc.2023.1244090

3,741 views
4 citations

Original Research

Published on 23 Aug 2023

An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma

in Cancer Immunity and Immunotherapy

Licheng Wang
Yaru Zhu
Zhen Ren
Wenhuizi Sun
Zhijing Wang
Tong Zi
Haopeng Li
Yan Zhao
Xin Qin
Dacheng Gao

Frontiers in Oncology

doi 10.3389/fonc.2023.1147805

1,507 views
5 citations

Original Research

Published on 22 Aug 2023

The identification of tumor antigens and immune subtypes based on the development of immunotherapies targeting head and neck squamous cell carcinomas resulting from periodontal disease

in Cancer Immunity and Immunotherapy

Yangju Fu
Yongbo Zheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1256105

1,566 views

Original Research

Published on 21 Aug 2023

Knowledge structure and hotspots research of glioma immunotherapy: a bibliometric analysis

in Cancer Immunity and Immunotherapy

Yexin Yuan
Yue Su
Yingxi Wu
Yafei Xue
Yunze Zhang
Yangyang Zhang
Min Zheng
Ting Chang
Yan Qu
Tianzhi Zhao

Frontiers in Oncology

doi 10.3389/fonc.2023.1229905

2,299 views

Original Research

Published on 21 Aug 2023

Upregulated FADD is associated with poor prognosis, immune exhaustion, tumor malignancy, and immunotherapy resistance in patients with lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Miao He
Yingying He
Jian Xu
Youcai Zhang
Xiaoyu Cao
Li Wang
Feng Luo

Frontiers in Oncology

doi 10.3389/fonc.2023.1228889

1,773 views
1 citation

Clinical Trial

Published on 16 Aug 2023

An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Yuwen Qi
Linping Gu
Jie Shen
Yaxian Yao
Yi Zhao
Shun Lu
Zhiwei Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1194100

1,631 views
1 citation

Original Research

Published on 11 Aug 2023

Typing and modeling of hepatocellular carcinoma based on disulfidptosis-related amino acid metabolism genes for predicting prognosis and guiding individualized treatment

in Cancer Immunity and Immunotherapy

Xuenuo Chen
Zhijian Wang
Yilin Wu
Yinghua Lan
Yongguo Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1204335

3,416 views
5 citations

Original Research

Published on 11 Aug 2023

A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma

in Cancer Immunity and Immunotherapy

Kirti Pandey
Stacie S. Wang
Nicole A. Mifsud
Pouya Faridi
Alexander J. Davenport
Andrew I. Webb
Jarrod J. Sandow
Rochelle Ayala
Michelle Monje
Ryan S. Cross

Frontiers in Oncology

doi 10.3389/fonc.2023.1192448

7,261 views
3 citations

Review

Published on 11 Aug 2023

Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases

in Cancer Immunity and Immunotherapy

Kelly H. Yoo
David J. Park
John H. Choi
Neelan J. Marianayagam
Michael Lim
Antonio Meola
Steven D. Chang

Frontiers in Oncology

doi 10.3389/fonc.2023.1223599

3,446 views
7 citations

Case Report

Published on 10 Aug 2023

Bilateral orbital plasmacytomas as first sign of extramedullary progression post CAR-T therapy: case report and literature review

in Cancer Immunity and Immunotherapy

Javier Nogués-Castell
Silvia Feu-Basilio
Óscar Felguera García
Carlos Fernández de Larrea
Aina Oliver-Caldés
Olga Balagué Ponz
Jessica Matas Fassi

Frontiers in Oncology

doi 10.3389/fonc.2023.1217714

1,811 views
1 citation

Systematic Review

Published on 09 Aug 2023

Prognostic role of IL-8 in cancer patients treated with immune checkpoint inhibitors: a system review and meta-analysis

in Cancer Immunity and Immunotherapy

Dan Zou
Ailin Song
Wei Yong

Frontiers in Oncology

doi 10.3389/fonc.2023.1176574

1,511 views
6 citations

Editorial

Published on 08 Aug 2023

Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors

in Cancer Immunity and Immunotherapy

Stefano Ugel
Chiara Bazzichetto
Fabiana Conciatori

Frontiers in Oncology

doi 10.3389/fonc.2023.1260183

936 views

Original Research

Published on 02 Aug 2023

Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal adenocarcinoma

in Cancer Immunity and Immunotherapy

Bicheng Ye
Qi Wang
Xiaofeng Zhu
Lingling Zeng
Huiyuan Luo
Yan Xiong
Qin Li
Qinmei Zhu
Songyun Zhao
Ting Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1236435

4,535 views
6 citations

Review

Published on 31 Jul 2023

Plants against cancer: the immune-boosting herbal microbiome: not of the plant, but in the plant. Basic concepts, introduction, and future resource for vaccine adjuvant discovery

in Cancer Immunity and Immunotherapy

Elizabeth Mazzio
Andrew Barnes
Ramesh Badisa
Stevie Council
Karam F. A. Soliman

Frontiers in Oncology

doi 10.3389/fonc.2023.1180084

4,719 views
1 citation

Navigation group

Articles

Targeting collagen in tumor extracellular matrix as a novel targeted strategy in cancer immunotherapy

Research progress of nanovaccine in anti-tumor immunotherapy

Harnessing the immunomodulatory effects of exercise to enhance the efficacy of monoclonal antibody therapies against B-cell haematological cancers: a narrative review

An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma

The identification of tumor antigens and immune subtypes based on the development of immunotherapies targeting head and neck squamous cell carcinomas resulting from periodontal disease

Knowledge structure and hotspots research of glioma immunotherapy: a bibliometric analysis

Upregulated FADD is associated with poor prognosis, immune exhaustion, tumor malignancy, and immunotherapy resistance in patients with lung adenocarcinoma

An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer

Typing and modeling of hepatocellular carcinoma based on disulfidptosis-related amino acid metabolism genes for predicting prognosis and guiding individualized treatment

A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma

Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases

Bilateral orbital plasmacytomas as first sign of extramedullary progression post CAR-T therapy: case report and literature review

Prognostic role of IL-8 in cancer patients treated with immune checkpoint inhibitors: a system review and meta-analysis

Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors

Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal adenocarcinoma

Plants against cancer: the immune-boosting herbal microbiome: not of the plant, but in the plant. Basic concepts, introduction, and future resource for vaccine adjuvant discovery